Column Group II, LP

Filings by Column Group II, LP span 2 companies, the busiest being RAPT Therapeutics, Inc. and Oric Pharmaceuticals, Inc. Between 18 August 2021 and 23 December 2024, the trades on record add up to 15 filings.

In open-market terms, that means 6 purchases worth €24.8M on one side and 3 sales worth €284k on the other. Netting one side against the other leaves €24.5M of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 option exercises.

A typical purchase (the median) is worth €116k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 23 December 2024 with a transaction in RAPT Therapeutics, Inc. The last insider purchase was made public on 27 May 2022, 1,605 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.